Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Naloxone hydrochloride 400mcg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 400mcg/mL injection solution 2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 400mcg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 20mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 400mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 2mg/2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Buprenorphine hydrochloride + naloxone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 2mg/2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely naloxone hydrochloride 40 microgram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 40 microgram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 800 microgram/2 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 800 microgram/2 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Naloxone hydrochloride 20 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Naloxone hydrochloride 20 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Naloxone hydrochloride dihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
|
Naloxone hydrochloride 20 mg/mL nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Naloxone hydrochloride 20 mg/mL nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 80 milligram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 80 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone (as naloxone hydrochloride) 1.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
1 |
Naloxone hydrochloride anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Naloxone hydrochloride |
Inferred relationship |
Some |
|